David Barker
About David Barker
Current Board Memberships
David Barker serves on the Boards of Directors of AmideBio, Aspen Neuroscience, and Bionano Genomics. In these roles, he contributes to strategic decision-making and provides guidance on scientific and business matters. His involvement with these companies emphasizes his ongoing commitment to advancing biotechnological innovations.
Advisory Roles
David Barker is a scientific advisor to Luna DNA, where he leverages his extensive experience in genomics and biotechnology to provide expert advice. His role involves offering insights into scientific research and advising on strategic initiatives to drive the company's growth and innovation.
Previous Executive Leadership
From 2000 to 2007, David Barker served as Vice President and Chief Scientific Officer at Illumina, Inc. During his tenure, he played a pivotal role in the company's scientific developments and innovations. He also held the position of Vice President and Chief Science Advisor at Amersham Biosciences, where he contributed to the company's scientific strategies and growth.
Past Board Memberships
David Barker has previously served on the boards of NextBio, ProteinSimple, Zephyrus Biosciences, IntegenX, and Integrated Diagnostics. By sitting on these boards, he provided critical oversight and strategic direction, contributing to the development and success of these companies within the biotechnology industry.
Academic and Research Background
David Barker holds a BS with honors in Chemistry from the California Institute of Technology and a PhD in Biochemistry from Brandeis University. He conducted interdisciplinary research in neurobiology as a postdoctoral fellow at Harvard Medical School. Furthermore, he has been an Assistant Professor at the University of Oregon and an Associate Professor at Oregon State University, where he contributed to academic research and education in the fields of chemistry and biochemistry.